ReviewWorld journal of microbiology & biotechnology2026
Harnessing the versatility of Sphingobium yanoikuyae: a review of its taxonomy, genomics, and multifaceted applications.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sphingobium yanoikuyae is a metabolically versatile, Gram-negative bacterium within the family Sphingobiaceae, recognized for its exceptional capacity to degrade a broad spectrum of xenobiotic compounds. Its ecological adaptability and enzymatic diversity enable the transformation of structurally complex pollutants into less toxic intermediates across diverse environmental settings. Although members of the genus Sphingobium have been widely studied, a focused and integrative synthesis specifically addressing the metabolic, genomic, and biotechnological attributes of S. yanoikuyae remains limited. This review presents a critical and up-to-date analysis of the taxonomy, genomic architecture, and xenobiotic degradation mechanisms of S. yanoikuyae, with particular emphasis on its functional role in microbial biotechnology. The organism exhibits broad substrate specificity toward hydrocarbons, pesticides, pharmaceuticals, and related compounds, mediated by coordinated enzymatic systems, including ring-hydroxylating dioxygenases, monooxygenases, and cytochrome P450-dependent pathways. Genomic analyses further reveal the presence of multiple catabolic operons, mobile genetic elements, and plasmid-associated gene clusters that collectively underpin its metabolic versatility, regulatory complexity, and adaptive potential. Beyond summarizing current knowledge, this review delineates key mechanistic features of degradation pathways, compares substrate-specific transformation efficiencies, and critically evaluates existing limitations, including incomplete pathway resolution, constraints in genetic manipulation, and variability in environmental performance. Furthermore, it highlights emerging opportunities in systems biology, enzyme engineering, and integrative omics approaches to enhance degradation efficiency and expand application scope. By consolidating current insights and identifying strategic research gaps, this work provides a coherent framework for advancing S. yanoikuyae as a robust platform for targeted applications in environmental remediation and sustainable biotechnology.
Indexed as
Identifiers
42068394What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.